$JCAP

Jefferson Capital, Inc. / DE (JCAP): Results of Operations and Financial Condition

Jefferson Capital, Inc. / DE (JCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jcap-20260813xex99d1.htm EX-99.1 ​ Exhibit 99.1 ​ Jefferson Capital Reports Second Quarter 2026 Results ​ Collections Grow 18% to $300.9 Million and Deployments grow 21% to $152.2 Million Estimated Remaining Collections (“ERC”) up 18% to $3.4 Billion Pre-tax Income of $

Original reporting
Published Aug 13, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$JCAP
Bullish
medium confidence
Mentioned
$JCAP
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$JCAPBullishMed
01

Why it matters

The disclosure provides fresh, quantified performance metrics (collections, deployments, ERC, revenue, income, EPS) and balance-sheet actions (RCF upsized, $300M deposit for 2026 notes repayment), which can affect valuation expectations and near-term trading flows.

02

Market read

Strong growth in collections and ERC, improved leverage, and positive earnings metrics are the main drivers, offset by higher operating expenses tied to servicing and court costs.

03

What to watch

The leverage ratio improved only modestly (1.71x vs 1.76x) while ERC growth is strong; traders may scrutinize whether cash efficiency (72.2%) can be sustained amid legal-cost inflation.

Relevance 7/10Novelty 8/10Timing: after-hours filing and same-day webcast (Aug 13, 2026)

Background

The 8-K (Item 2.02) includes Exhibit 99.1 with Jefferson Capital’s Q2 2026 operating and financial results, plus liquidity/capital updates and a declared quarterly dividend.

Company-level read

Ticker impact

$JCAPBullishMedium confidence
Context

Jefferson Capital reported Q2 2026 results, including collections up 18% to $300.9M, ERC up 18% to $3.4B, and EPS of $0.67.

Expected impact

Moderately positive bias for the next session as traders price in stronger collections/deployments and improved leverage, with attention to higher operating expenses.

Evidence & confidence

The filing is a primary earnings-style disclosure with multiple quantified KPIs (collections, deployments, ERC, cash efficiency, leverage) and concrete balance-sheet/capital actions (RCF upsized, $300M deposit for 2026 notes repayment).

Market effects

Supports the broader charged-off/consumer receivables purchase-and-servicing model narrative that portfolio supply and credit quality dynamics can translate into earnings growth.

Highlights continued growth across US, Canada, UK, and Latin America, which may matter for regional risk appetite in consumer credit.

Limited direct global spillover, but reinforces cross-border receivables purchasing demand and execution capability.

Counterpoint

Operating expenses rose sharply (+45.6%) due to servicing and higher court costs, which could cap upside if collections growth slows.

Key entities

  • Jefferson Capital, Inc. (DE)

    Subject of the 8-K, reporting Q2 2026 results and capital/liquidity actions.

  • Revolving Credit Facility (RCF)

    RCF commitments increased to $1.15B on April 22, 2026; $226M drawn at June 30, 2026.

  • 2026 notes

    Company deposited $300M with the bond trustee on Aug 13, 2026 for expected repayment on Aug 17, 2026.

Related articles

$LFTMed

Lument Finance Trust, Inc. (LFT): Results of Operations and Financial Condition

Lument Finance Trust, Inc. (LFT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 tm2623066d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 August 2026 Lument Finance Trust Q2 2026 Earnings Supplemental Disclaimer 2 This presentation contains forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section

$TILMed

Instil Bio, Inc. (TIL): Results of Operations and Financial Condition

Instil Bio, Inc. (TIL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2-26er.htm EX-99.1 Document Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update DALLAS, TX, August 13, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing in

$MPLTMed

MapLight Therapeutics, Inc. (MPLT): Results of Operations and Financial Condition

MapLight Therapeutics, Inc. (MPLT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-10.1 3 d48818dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “ Agreement ”) is dated as of August 13, 2026, by and among MapLight Therapeutics, Inc., a Delaware corporation (the “ Company ”), and each of the purcha

$RNAMed

Atrium Therapeutics, Inc. (RNA): Results of Operations and Financial Condition

Atrium Therapeutics, Inc. (RNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d149126dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Atrium Therapeutics Reports Second Quarter 2026 Financial Results — IND clearance for ATR 1072 and launch of Corventis Phase 1/2 trial in PRKAG2 syndrome — — Achieved second milestone payment under global cardiovascular col

$CLDIMed

Calidi Biotherapeutics, Inc. (CLDI): Results of Operations and Financial Condition

Calidi Biotherapeutics, Inc. (CLDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Received positive pre-IND feedback from the U.S. FDA for CLD-401, indicating agreement on the current development strategy toward a firs

$LOGCMed

ContextLogic Holdings Inc. (LOGC): Results of Operations and Financial Condition

ContextLogic Holdings Inc. (LOGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 logc-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 ContextLogic Holdings Inc. Reports Second-Quarter 2026 Financial Results OAKLAND, Calif., August 13, 2026 ( GLOBE NEWSWIRE ) -- ContextLogic Holdings Inc. (OTCQB: LOGC) ("ContextLogic," the "Company," "we" or "our") today rep